RMCM
REGN icon

Reynders McVeigh Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Reynders McVeigh Capital Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-286
Closed -$251K – 204
2023
Q4 		$251K Hold
286
– – 0.02% 176
2023
Q3 		$235K Buy
286
+5
+2% +$3.93K 0.02% 180
2023
Q2 		$202K Sell
281
-1
-0.4% -$771 0.01% 199
2023
Q1 		$232K Hold
282
– – 0.02% 188
2022
Q4 		$203K Sell
282
-387
-58% -$286K 0.01% 207
2022
Q3 		$461K Hold
669
– – 0.04% 145
2022
Q2 		$395K Sell
669
-7
-1% -$4.55K 0.03% 164
2022
Q1 		$472K Sell
676
-25
-4% -$15.8K 0.03% 164
2021
Q4 		$443K Sell
701
-238
-25% -$146K 0.03% 169
2021
Q3 		$568K Sell
939
-323
-26% -$201K 0.03% 143
2021
Q2 		$705K Sell
1,262
-127
-9% -$64.3K 0.04% 127
2021
Q1 		$657K Sell
1,389
-174
-11% -$84.7K 0.04% 136
2020
Q4 		$755K Sell
1,563
-154
-9% -$83.1K 0.05% 123
2020
Q3 		$961K Sell
1,717
-80
-4% -$48.5K 0.07% 100
2020
Q2 		$1.12M Sell
1,797
-45
-2% -$25.5K 0.1% 94
2020
Q1 		$899K Buy
1,842
+7
+0.4% +$2.89K 0.1% 96
2019
Q4 		$689K Hold
1,835
– – 0.07% 133
2019
Q3 		$509K Hold
1,835
– – 0.05% 141
2019
Q2 		$574K Hold
1,835
– – 0.06% 134
2019
Q1 		$753K Buy
1,835
+500
+37% +$206K 0.08% 118
2018
Q4 		$499K Buy
+1,335
New +$489K 0.07% 127

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Reynders McVeigh Capital Management's REGN Position: Q1 2024 in Review

Reynders McVeigh Capital Management sold out of Regeneron Pharmaceuticals (REGN) in Q1 2024, closing a stake of 286 shares — an estimated $251K sold.

Reynders McVeigh Capital Management first reported a position in REGN in Q4 2018 and held it in 21 quarters. The position peaked at $1.12M in Q2 2020. 1,312 funds tracked by Wall St. Rank hold REGN as of Q1 2024.

  • Reynders McVeigh Capital Management reported no remaining Regeneron Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Reynders McVeigh Capital Management sold 286 Regeneron Pharmaceuticals shares in Q1 2024, an estimated $251K.
  • Reynders McVeigh Capital Management first reported a position in Regeneron Pharmaceuticals in Q4 2018 and held it in 21 quarters.
  • Reynders McVeigh Capital Management's Regeneron Pharmaceuticals position peaked at $1.12M in Q2 2020.
  • 1,312 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2024.

Based on Reynders McVeigh Capital Management's 13F filing for Q1 2024, filed 7 May 2024.